Cost-Effectiveness Evaluation of a Quadrivalent Human Papillomavirus Vaccine in Belgium

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.27, Iss.5, 2009-05, pp. : 433-433

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost-Effectiveness Evaluation of a Quadrivalent Human Papillomavirus Vaccine in Belgium

By Annemans Lieven

PharmacoEconomics, Vol. 27, Iss. 3, 2009-01 ,pp. : 231-245

Adis International

Access to resources Recommend Favorite

Effectiveness and Cost Effectiveness of Human Papillomavirus Vaccine: A Systematic Review

By Marra Fawziah Cloutier Karine

PharmacoEconomics, Vol. 27, Iss. 2, 2009-01 ,pp. : 127-147

Adis International

Access to resources Recommend Favorite

Human papillomavirus vaccine recombinant quadrivalent: Brachial plexus neuritis: case report

Reactions Weekly, Vol. 1, Iss. 1218, 2008-01 ,pp. : 18-19

Adis International

Access to resources Recommend Favorite

Human papillomavirus vaccine recombinant quadrivalent: Subcutaneous emphysema: case report

Reactions Weekly, Vol. 1, Iss. 1261, 2009-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Human papillomavirus vaccine recombinant quadrivalent: Various toxicities: 8 case reports

Reactions Weekly, Vol. 1, Iss. 1277, 2009-01 ,pp. : 24-25

Adis International

Access to resources Recommend Favorite